the pd-l1 negative control cell line Search Results


the pd-l1 negative control cell line  (IncellDx Inc)
90
IncellDx Inc the pd-l1 negative control cell line
Workflow for CTC capture and <t>PD-L1</t> analysis
The Pd L1 Negative Control Cell Line, supplied by IncellDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+pd-l1+negative+control+cell+line/the+pd+l1+negative+control+cell+line/pmc06584214-139-8-16
Average 90 stars, based on 1 article reviews
the pd-l1 negative control cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Workflow for CTC capture and PD-L1 analysis

Journal: Cancer Immunology, Immunotherapy

Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

doi: 10.1007/s00262-019-02344-6

Figure Lengend Snippet: Workflow for CTC capture and PD-L1 analysis

Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

Techniques:

Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive

Journal: Cancer Immunology, Immunotherapy

Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

doi: 10.1007/s00262-019-02344-6

Figure Lengend Snippet: Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive

Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

Techniques: Immunohistochemistry, Positive Control

PD-L1 expression levels in ten cancer cell lines and in PD-L1 positive and negative control cells from the BioINK staining kit

Journal: Cancer Immunology, Immunotherapy

Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

doi: 10.1007/s00262-019-02344-6

Figure Lengend Snippet: PD-L1 expression levels in ten cancer cell lines and in PD-L1 positive and negative control cells from the BioINK staining kit

Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

Techniques: Expressing, Negative Control, Staining

Example images of PD-L1 positive and negative staining patterns

Journal: Cancer Immunology, Immunotherapy

Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

doi: 10.1007/s00262-019-02344-6

Figure Lengend Snippet: Example images of PD-L1 positive and negative staining patterns

Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

Techniques: Negative Staining

CTC detection rate and PD-L1% in treatment-naïve NSCLC patients

Journal: Cancer Immunology, Immunotherapy

Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

doi: 10.1007/s00262-019-02344-6

Figure Lengend Snippet: CTC detection rate and PD-L1% in treatment-naïve NSCLC patients

Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

Techniques:

2 × 2 Confusion matrix and performance measures

Journal: Cancer Immunology, Immunotherapy

Article Title: Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer

doi: 10.1007/s00262-019-02344-6

Figure Lengend Snippet: 2 × 2 Confusion matrix and performance measures

Article Snippet: The PD-L1 positive control cell line and the PD-L1 negative control cell line were obtained from InCellDx, Inc. (IncellDx, Menlo Park, CA, USA).

Techniques: